跳至主要内容
临床试验/TCTR20240427002
TCTR20240427002进行中(未招募)不适用

Effects of generic risedronate on bone turnover markers and bone mineral density in Thai postmenopausal osteoporosis.

Ratchadapisek Research Funds0 个研究点目标入组 80 人开始时间: 2024年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
45 Years 至 75 Years(—)
性别
Female

入选标准

  • 1.postmenopausal osteoporotic women (not menstruated for at least 1 year)
  • 2.diagnosed with osteoporosis by Dual-energy X-ray Absorptiometry (DXA) with a T-score < 2.5 at the total lumbar spine or L1-L4, femoral neck, or total hip for at least one site

排除标准

  • 1. had been treated for osteoporosis in 12 months
  • 2. had medications known to interfere with BTMs such as corticosteroids and antiepileptic drugs
  • 3. had recent fracture in the 12 months
  • 4.known case thyroid disorders
  • 5.parathyroid disorders
  • 6.renal insufficiency
  • 7.rheumatoid disease
  • 8.Cushing disease
  • 9.multiple myeloma and
  • 10.cancers involving bone health
  • 11.unable to sit or stand in an upright position for at least 30 mins after taking medications 12.experiencing severe upper gastrointestinal tract symptoms

研究者

发起方
Ratchadapisek Research Funds

相似试验

Effects of generic risedronate on bone turnover... | 临床试验